218 related articles for article (PubMed ID: 21733911)
1. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
[TBL] [Abstract][Full Text] [Related]
2. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
3. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).
Mathew JS; Sachs MC; Katz R; Patton KK; Heckbert SR; Hoofnagle AN; Alonso A; Chonchol M; Deo R; Ix JH; Siscovick DS; Kestenbaum B; de Boer IH
Circulation; 2014 Jul; 130(4):298-307. PubMed ID: 24920722
[TBL] [Abstract][Full Text] [Related]
6. Predictors of atrial fibrillation after coronary artery bypass surgery.
Dogan SM; Buyukates M; Kandemir O; Aydin M; Gursurer M; Acikgoz S; Yavuzer R; Cam F; Dursun A
Coron Artery Dis; 2007 Aug; 18(5):327-31. PubMed ID: 17627180
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
[TBL] [Abstract][Full Text] [Related]
8. Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study.
Foley RN; Collins AJ; Herzog CA; Ishani A; Kalra PA
Kidney Blood Press Res; 2009; 32(1):37-44. PubMed ID: 19229116
[TBL] [Abstract][Full Text] [Related]
9. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
Saura D; Marín F; Climent V; González J; Roldán V; Hernández-Romero D; Oliva MJ; Sabater M; de la Morena G; Lip GY; Valdés M
Int J Clin Pract; 2009 Oct; 63(10):1465-71. PubMed ID: 19769703
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
11. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
12. Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad N; Barnett SD; Haan CK; O'Brien SM; Milford-Beland S; Speir AM
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):901-6. PubMed ID: 19327515
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG
Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702
[TBL] [Abstract][Full Text] [Related]
14. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.
Viaene L; Bammens B; Meijers BK; Vanrenterghem Y; Vanderschueren D; Evenepoel P
Nephrol Dial Transplant; 2012 May; 27(5):2017-22. PubMed ID: 22025115
[TBL] [Abstract][Full Text] [Related]
15. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
18. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
19. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
20. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
